These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1521 related articles for article (PubMed ID: 23665962)

  • 1. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells.
    Commisso C; Davidson SM; Soydaner-Azeloglu RG; Parker SJ; Kamphorst JJ; Hackett S; Grabocka E; Nofal M; Drebin JA; Thompson CB; Rabinowitz JD; Metallo CM; Vander Heiden MG; Bar-Sagi D
    Nature; 2013 May; 497(7451):633-7. PubMed ID: 23665962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR-Pak Signaling Selectively Regulates Glutamine Deprivation-Induced Macropinocytosis.
    Lee SW; Zhang Y; Jung M; Cruz N; Alas B; Commisso C
    Dev Cell; 2019 Aug; 50(3):381-392.e5. PubMed ID: 31257175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma membrane V-ATPase controls oncogenic RAS-induced macropinocytosis.
    Ramirez C; Hauser AD; Vucic EA; Bar-Sagi D
    Nature; 2019 Dec; 576(7787):477-481. PubMed ID: 31827278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYRI-B-mediated macropinocytosis drives metastasis via lysophosphatidic acid receptor uptake.
    Nikolaou S; Juin A; Whitelaw JA; Paul NR; Fort L; Nixon C; Spence HJ; Bryson S; Machesky LM
    Elife; 2024 May; 13():. PubMed ID: 38712822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A recombinantly tailored β-defensin that displays intensive macropinocytosis-mediated uptake exerting potent efficacy against K-Ras mutant pancreatic cancer.
    Du Y; Shang BY; Sheng WJ; Zhang SH; Li Y; Miao QF; Zhen YS
    Oncotarget; 2016 Sep; 7(36):58418-58434. PubMed ID: 27517152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catabolic pathways regulated by mTORC1 are pivotal for survival and growth of cancer cells expressing mutant Ras.
    Sung S; Choi J; Cheong H
    Oncotarget; 2015 Dec; 6(38):40405-17. PubMed ID: 26575954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism: Taking it all in.
    Seton-Rogers S
    Nat Rev Cancer; 2013 Jul; 13(7):438. PubMed ID: 23739049
    [No Abstract]   [Full Text] [Related]  

  • 8. The pervasiveness of macropinocytosis in oncological malignancies.
    Commisso C
    Philos Trans R Soc Lond B Biol Sci; 2019 Feb; 374(1765):20180153. PubMed ID: 30967003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin-binding associated protein 2 regulates KRAS activation and macropinocytosis in pancreatic cancer.
    Xiong X; Rao G; Roy RV; Zhang Y; Means N; Dey A; Tsaliki M; Saha S; Bhattacharyya S; Dhar Dwivedi SK; Rao CV; McCormick DJ; Dhanasekaran D; Ding K; Gillies E; Zhang M; Yang D; Bhattacharya R; Mukherjee P
    FASEB J; 2020 Sep; 34(9):12024-12039. PubMed ID: 32692445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phellodendrine chloride suppresses proliferation of KRAS mutated pancreatic cancer cells through inhibition of nutrients uptake via macropinocytosis.
    Thu PM; Zheng ZG; Zhou YP; Wang YY; Zhang X; Jing D; Cheng HM; Li J; Li P; Xu X
    Eur J Pharmacol; 2019 May; 850():23-34. PubMed ID: 30716311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors.
    Davidson SM; Jonas O; Keibler MA; Hou HW; Luengo A; Mayers JR; Wyckoff J; Del Rosario AM; Whitman M; Chin CR; Condon KJ; Lammers A; Kellersberger KA; Stall BK; Stephanopoulos G; Bar-Sagi D; Han J; Rabinowitz JD; Cima MJ; Langer R; Vander Heiden MG
    Nat Med; 2017 Feb; 23(2):235-241. PubMed ID: 28024083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and Quantification of Macropinosomes in Pancreatic Tumors.
    Lee SW; Alas B; Commisso C
    Methods Mol Biol; 2019; 1882():171-181. PubMed ID: 30378054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway.
    Son J; Lyssiotis CA; Ying H; Wang X; Hua S; Ligorio M; Perera RM; Ferrone CR; Mullarky E; Shyh-Chang N; Kang Y; Fleming JB; Bardeesy N; Asara JM; Haigis MC; DePinho RA; Cantley LC; Kimmelman AC
    Nature; 2013 Apr; 496(7443):101-5. PubMed ID: 23535601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macropinocytosis: A Metabolic Adaptation to Nutrient Stress in Cancer.
    Recouvreux MV; Commisso C
    Front Endocrinol (Lausanne); 2017; 8():261. PubMed ID: 29085336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein.
    Kamphorst JJ; Nofal M; Commisso C; Hackett SR; Lu W; Grabocka E; Vander Heiden MG; Miller G; Drebin JA; Bar-Sagi D; Thompson CB; Rabinowitz JD
    Cancer Res; 2015 Feb; 75(3):544-53. PubMed ID: 25644265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAS-Driven Macropinocytosis of Albumin or Dextran Reveals Mutation-Specific Target Engagement of RAS p.G12C Inhibitor ARS-1620 by NIR-Fluorescence Imaging.
    Sutton MN; Gammon ST; Muzzioli R; Pisaneschi F; Radaram B; Yang P; Piwnica-Worms D
    Mol Imaging Biol; 2022 Jun; 24(3):498-509. PubMed ID: 34905147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gold Nanoparticles Inhibit Macropinocytosis by Decreasing KRAS Activation.
    Elechalawar CK; Rao G; Gulla SK; Patel MM; Frickenstein A; Means N; Roy RV; Tsiokas L; Asfa S; Panja P; Rao C; Wilhelm S; Bhattacharya R; Mukherjee P
    ACS Nano; 2023 May; 17(10):9326-9337. PubMed ID: 37129853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-content, full genome siRNA screen for regulators of oncogenic HRAS-driven macropinocytosis.
    Fennell M; Commisso C; Ramirez C; Garippa R; Bar-Sagi D
    Assay Drug Dev Technol; 2015 Sep; 13(7):347-55. PubMed ID: 26267765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macropinocytosis in Cancer-Associated Fibroblasts Is Dependent on CaMKK2/ARHGEF2 Signaling and Functions to Support Tumor and Stromal Cell Fitness.
    Zhang Y; Recouvreux MV; Jung M; Galenkamp KMO; Li Y; Zagnitko O; Scott DA; Lowy AM; Commisso C
    Cancer Discov; 2021 Jul; 11(7):1808-1825. PubMed ID: 33653692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Macropinocytosis-Intensifying Albumin Domain-Based scFv Antibody and Its Conjugate Directed against K-Ras Mutant Pancreatic Cancer.
    Wang X; Sheng W; Wang Y; Li L; Li Y; Zhang S; Liu X; Chen S; Zhen Y
    Mol Pharm; 2018 Jun; 15(6):2403-2412. PubMed ID: 29757658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 77.